Skip to Content

Health

A sign for the Food And Drug Administration is seen outside of the headquarters in White Oak

FDA moves to fast-track review of psilocybin and methylone for mental health

New

By Jacqueline Howard, CNN (CNN) — Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental health treatments in the United States. The US Food and Drug Administration on Friday issued national priority vouchers to three companies studying these psychedelic-based medicines: psilocybin, the active ingredient

Continue Reading
Measles cases in the US have topped 1

Newer testing methods suggest significant silent spread of measles in the US, threatening elimination

By Brenda Goodman, CNN (CNN) — Measles crept into Utah and Arizona in June, with reports trickling into local health departments of patients coming to doctors and saying their children had just recovered from full-body rashes, and parents telling pediatricians that their whole family had just recovered from measles. But because patients would decline testing,

Continue Reading
A man pulls iboga roots from the ground

Ibogaine is drawing new interest from the Trump administration. Here’s what to know about the psychedelic

By Michal Ruprecht, Jacqueline Howard, CNN (CNN) — Psychedelic drugs, once pushed to the fringes of medicine, are gaining serious attention within the Trump administration as potential treatment options for people with certain mental health conditions. And they could be getting closer to receiving approval from the US Food and Drug Administration. President Donald Trump

Continue Reading
Dr. Erica Schwartz is being nominated to lead the US Centers for Disease Control and Prevention.

Public health veteran is Trump’s pick to lead CDC as administration shifts tone on vaccines

By Sarah Owermohle, Brenda Goodman, Adam Cancryn, CNN (CNN) — President Donald Trump’s new pick to lead the US Centers for Disease Control and Prevention is a public health veteran who has led vaccination programs, a new sign of the administration’s shifting views on vaccines. Dr. Erica Schwartz’s nomination to lead the embattled agency came

Continue Reading